Pharma Market Access Insights - from Mtech Access

Here, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies.

Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be appropriate for your product? What will payers, HTA agencies, and other key decision makers be looking for? And how should this information be presented?

In this episode, our experts in HTA, health economics, and commercialisation explore:
- How to identify and communicate the value of your product for patients and the wider healthcare system
- How to build a robust evidence package for successful launch and commercialisation
- Key requirements for the National Institute for Health and Care Excellence (NICE) Medical Technologies Evaluation Programme (MTEP) or Diagnostics Assessment Programme (DAP)
- Next steps to take your innovation to healthcare leaders across the NHS and beyond, with an impactful customer communication strategy

This episode was first broadcast as a live webinar in January 2023. Learn more and request a copy of the slides at: https://mtechaccess.co.uk/evidence-strategy-for-medical-technologies-and-diagnostics/

Discover how Mtech Access can support your commercialisation journey at: https://mtechaccess.co.uk/medical-device-market-access/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market.

Clare Foy (Director – Global Market Access, Mtech Access) speaks to Janice MacLennan (Pharma and Medtech brand strategist and founder of NMBLR) about how market access, HEOR and commercialisation leads in Pharma and Medtech can best support overarching product and brand strategy, with a focus on launch challenges in the US market.

We take a step back from the intricacies of market access and HEOR, to explore the role our specialism plays in broader commercial and product strategy. We ask: where does market access and HEOR sit in this broader picture, and how can market access teams best support their product and company brand?

Using the US market as our case study, we explore:

- How to set up your product for success
- Commercialisation routes in the US for Pharma and Medtech
- The relationship between brand strategy and market access
- What Pharma can learn from Medtech’s approach to commercialisation
- What Medtech innovators can learn from Pharma companies’ approach to launch

This episode was first broadcast as a live webinar in January 2024.

Learn more at: https://mtechaccess.co.uk/commercialisation-strategy-us-market/

Explore our work in the US market: https://mtechaccess.co.uk/launching-healthcare-products-in-the-us/

Discover how Mtech Access can support you global market access and pricing strategy: https://mtechaccess.co.uk/global-market-access-and-pricing/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?

Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in the NHS and what to expect as we head into 2024.

Malcolm Qualie and David Thorne explored:

• Specialised commissioning in the NHS
• The risks and opportunities that devolution to ICBs will bring
• What we can expect to see in the short and longer term
• How industry can support ICB leaders through this transition
• How Pharma, Medtech, and Diagnostics companies, whose products come under specialised commissioning, can manage these risks and uncertainties

Learn more at https://mtechaccess.co.uk/nhs-specialised-commissioning/

This episode first broadcast as a live webinar in Decmeber 2023. 

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

What does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England?

Paul Mears (CEO, Cwm Taf Morgannwg University Health Board) joins Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) to explore the integrated care model in Wales and the lessons England can take from the Welsh experience.

In this NHS Whispers webinar, guest speaker Paul Mears shares his experiences leading a Welsh health board. The 7 Health Boards in Wales have been operating as integrated systems for over a decade. With the NHS in England just getting to grips with integration, we explore what England can learn from the Welsh experience.

Robert and Paul explore:
 - How NHS Wales is structured and who the key decision makers are
 - How the integrated healthcare system works in Wales and how this differs to what’s happening in England
 - How priorities are set and what shapes decision-making at health board level
 - The nuances of the Welsh health system and what this means for industry
 - How Welsh Health Boards work with industry and the lessons here for ICBs and industry in England
 - Prudent healthcare and what this means in practice
 - How industry can best engage with health board leaders, what channels to use, and what messages to bring

This episode was first broadcast live as webinar in November 2023

Learn more about this webinar at: https://mtechaccess.co.uk/integrated-care-in-nhs-wales/

Discover how we can help you with your NHS engagement and UK market access strategy at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Clare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA).

We explore:
- The nature of the Italian market and the reimbursement process
- Pricing and market access considerations when launching in Italy
- What the reforms at AIFA mean for market access and managed entry agreements
- How the AIFA changes specifically impact innovative products
- Changes to early access programmes in Italy
- Impact of these changes on international pricing, particularly with the introduction of the EU Joint Clinical Assessment (JCA)

This episode was first broadcast as a live webinar in October 2023. Learn more at: https://mtechaccess.co.uk/italy-market-access-aifa-reforms/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond.

Former ‘GP of the year’ and strategic influencer over primary care policy, Dr Farzana Hussain, discusses the unmet needs in primary care, how primary care leaders are responding to these challenges, and where industry can best offer support.

Phil and Farzana discuss:

•  How unmet needs are identified in primary care, the processes followed, and datasets used to inform decision making
•  The specific challenges facing primary care as we head into winter
•  The role of PCN leaders and their impact on national policy
•  How industry can best support and collaborate with PCNs
•  Ongoing lessons from the pandemic and the vaccine roll-out

Learn more about this webinar at: https://mtechaccess.co.uk/unmet-need-nhs-primary-care/

Discover or NHS Insight and UK market access services: https://mtechaccess.co.uk/uk-nhs-insights/

This episode was first broadcast as a live webinar in October 2023. 

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

How can our community support NHS leaders to deliver a data-led, people-centric health service?

Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHS’s population health management goals.

Population health management has the potential to be a powerful tool for healthcare systems, effecting the way health and care is strategised, budgeted, targeted, and delivered. We see a future where key decisions in the NHS are driven by population health data. What we now need is a new way of working powered by local need, quality evidence and a systematic approach.

In this webinar, Phil and Mark explore:

 - How the NHS can use population health management to transform the system
 - The importance of community in population health management
 - How Pharma, Medtech, and the wider life sciences sector can work above brand to support the NHS with population health management
 - What a data-driven, people-centric approach means for the way treatments are valued
 - How population health management could transform the economics of healthcare

This episode was first broadcast as a live webinar on Friday 8th September 2023. Learn more at: https://mtechaccess.co.uk/uk-nhs-insights/

Discover more about our work in this area at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access?

In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of ophthalmology. George and Calum explore:

- How, when and where AI is being used in clinical trials
- How Lexitas are using AI in clinical trials for ophthalmology
- Where AI may offer solutions to existing obstacles in clinical trials and ophthalmic drug development
- What the future holds for AI in the development of new medicines
- The role AI can play in selecting patients for clinical trials
- The impact AI may have on the way we evaluate drug effectiveness
- What this all means for evidence synthesis, health economics, reimbursement and market access
- The future prospects of AI in pharmaceutical development

Learn more at: https://mtechaccess.co.uk/ai-clinical-trials-evidence/

This episode was first broadcast as a live webinar in August 2023. 

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators?

Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for Medtech, Health technologies, and Medical Device market access.

With the challenges of the pandemic and the changes brought in following Brexit, policy and compliance in the UK has been on shifting sands for several years now. With many predicting a change in government at the next election, this continues to be a time of uncertainty. What does this political landscape mean for health policy, the regulatory regime and market access?

In this on-demand webinar, Rob asks Bill about 6 areas where Medtech should be paying attention:

• MHRA and new medical device regulatory regime
• UK health and social care supply and procurement
• Sustainability and social value
• Addressing capacity challenges with effective health and social care packages
• Innovation
• Export and import – the implications of Brexit

This episode was first broadcast as a live webinar in July 2023.  Learn more about this webinar at:  https://mtechaccess.co.uk/uk-health-policy-medtech-bhta-webinar/

Learn more about our services for Medtech companies at: https://mtechaccess.co.uk/medical-device-market-access/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets.

Clare and Stefan discuss:
 - Preparing for access to Switzerland – a European market outside the EU
 - Pricing strategy and HTA decision-making in Austria under the new Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)
 - Launching in Germany – is this still one of the most attractive European markets?
 - The Financial Stabilisation Act in Germany – what this means for drug pricing

Learn more at: https://mtechaccess.co.uk/market-acce...

This episode was first broadcast as a live webinar in July 2023. 

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

How are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can Medtech, Digital and Biotech innovators collaborate with the front-line nursing teams in the NHS to drive transformation?

Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) speaks to Jennie Smith, registered nurse, Medtech launch specialist and our new Director of NHS Insight & Interaction at Mtech Access.

Phil and Jennie explore:

 - The transformative power of technology in the NHS; particularly on patient pathways
 - The role of nurses in digital transformation and the adoption and implementation of new technologies
 - Key nursing champions, including Chief Nurse Information Officers (CNIOs)
 - How industry can best support the NHS with digital transformation
 - Our plans to bring together NHS and industry for greater collaboration

This episode was originally broadcast as a live webinar in June 2023. Learn more at: https://mtechaccess.co.uk/nursing-driving-digital-change-nhs/

Learn more about our NHS Insight & Interaction services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcomes.

In the webinar, Clare asks Shefali about:

• The opportunities for digital technologies in neurology and how they may impact existing care pathways in the future
• How the digital technology market differs from the pharmaceutical market
• Regulatory and reimbursement challenges for digital technologies
• Her experiences in launching digital technologies in markets such as the US and Germany
• How digital technologies can be used to enhance and complement existing treatments/pathways of care
• Lessons other digital health, medical device and pharmaceutical companies can learn from Shefali’s experiences

The episode was first broadcast as a live webinar in June 2023.  Learn more about this webinar at https://mtechaccess.co.uk/market-access-for-digital-therapies/

Learn how Mtech Access can support you with your market access journey at: https://mtechaccess.co.uk/global-market-access-and-pricing/ 

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

What does it take to bring a cannabinoid pharmaceutical to market?

We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the Pharma industry can learn from their journey.

In the webinar, Clare asked Michael about:
- Drug development and clinical trial processes for medical cannabis products
 - Differences between the herbal medicines market and the Pharmaceutical market
 - Overcoming regulatory and reimbursement challenges
 - Finding the right place for cannabinoid medicines within existing pathways of care
 - Perceptions, pathways and routes to access in different markets
 - Lessons for the wider Pharma and Biotech industries

Learn more about this webinar and our guest speaker Michael Sassano at: https://mtechaccess.co.uk/global-market-access-journey-cannabinoid-pharmaceuticals/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

How will changes to the structure of primary care impact decision making?
How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows be impacted?

Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Tim Goodson (Executive Officer, Dorset General Practice Alliance) to explore how primary care is evolving and what this means for decision making, funding, and relationships with industry.

Phil and Tim explore:

• The integration journey across primary care
• Evolving relationships and structures in primary care in the NHS
• Where decisions are made and who makes them
• How understanding commissioning priorities and funding flows can help Pharma and Medtech to identify decision makers and understand their needs

This episode was first broadcast as a live webinar on Friday 28th April 2023.
For more information please see: https://mtechaccess.co.uk/primary-care-integration-journey/

Learn more about how Mtech Access UK NHS Insight services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Is data the key to transforming healthcare systems and patient care?

What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner with the NHS to share data, transform services, and find smarter, faster way to improve patient care?

Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Stephen Slough (Chief Digital Information Officer, NHS Dorset) to explore how, through the catalyst of partnership, new technologies and data have the potential to transform healthcare.

We have reached a point where digital is so ubiquitous that, even in the NHS, what were previously seen as ‘digital’ transformation projects are now viewed as simply business transformation projects.

Add in advancements in artificial intelligence and ChatGPT-type services, along with the potential of big data, and it’s no surprise that digital is at the heart of transformation in the NHS.

In this episode, Phil and Stephen explore:

 - The digital landscape for NHS decision makers
 - How, when and where data can transform healthcare systems and patient care
 - How the NHS and industry can get access to and share our data to better plan products and services
 - What the top priorities are for digital leaders
 - How industry build strategic partnerships with Integrated Care Boards (ICBs) and other NHS leaders driving data-led transformation

This podcast was originally broadcast as a live webinar. Learn more at: https://mtechaccess.co.uk/data-led-transformation-nhs/

To learn more about our work with the NHS and how we support our Pharma and Medtech clients visit:  https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

How and where can innovation drive improvements in care and deliver better health for the population?
How is the NHS looking to collaborate with key partners across industry and academia? What innovations are set to transform care? What role do Academic Health Science Networks (AHSNs) play and how can partners best engage with them?

Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Bill Gillespie (Chief Executive Officer, Wessex AHSN) to explore innovation in the NHS, the role of AHSNs and the potential for greater collaboration across our sector, in our latest NHS Whispers webinar.

Learn more at: https://mtechaccess.co.uk/innovating-for-better-health/

The episode was was originally broadcast as a live webinar on 24th February 2023.

Discover our NHS Insights services and how we can support Medtech innovations achieve market access.

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change?

What social and economic value do ICSs offer the wider population they serve? How will industry support ICSs to deliver population-based health and social benefits?

Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Michael Wood (Head of Health Economic Partnerships, NHS Confed) for a far-reaching discussion around system integration, population health management, and the NHS’s social and economic potential.

In December (2022), Michael Wood authored a report exploring one of the four key purposes of an ICS: to help the NHS support broader social and economic development. Michael’s NHS Confed report looked at the economics of healthcare and where broader strategic partnership working might lead system thinking in the NHS.

Phil Richardson was one of several experienced ICS, local authority, university and professional experts that Michael invited to share their perspectives in the report.

We were delighted to bring Michael and Phil together in this webinar to discuss these topics, particularly in light of what these new leadership purposes mean for the NHS’s relationship with the Pharmaceutical and wider Life Science industries.

In the webinar, Phil and Michael discuss:

• NHS Confed and the links between the health sector and the economy
• The need for ICS leaders to focus on broader social and economic development
• How Pharma and Medical Device companies can add value to support this key ICS purpose
• Why health and economic development is key to tackling health inequalities
• The important role the NHS plays as an anchor institution that links better health with economic and social development
• What health and economic development could mean for funding at different levels of an integrated system – e.g. place based commissioning
• Opportunities for industry to step up and support the NHS with economic and social development

Learn more about this webinar here

Learn more about our work with the NHS

This episode was first broadcast as a live webinar in January 2023

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

The proposed new NHSE systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects or policy have been published in ways that are hard to access and even harder to interpret. Here, we gather an expert panel to discuss what proposed new NHSE systems for specialised commissioning mean in practice.

In this episode, we explore:
 - What’s new for Specialised Commissioning and what’s set to change?
 - What are the potential implications of the proposed changes recently published?
 - Integrated Care Boards (ICBs) and their increasing role with Specialised Commissioning
 - What this means for the NHS and for industry in practice

The episode begins with an overview and analysis of the changes from David Thorne (Principal Associate, Mtech Access and Business Development Director, Well Up North PCN). David then opens up a broader discussion about the implications of these changes with our guest panellists James Curtis (Deputy Operational Director, Gloucestershire NHS Foundation Trust) and Mohammed Asghar (ICS Prescribing Governance Lead at Frimley Health and Care ICS).

The episode was originally broadcast as a live webinar on 2nd December 2022.
Learn more at: https://mtechaccess.co.uk/specialised-commissioning-nhs/

Find our more about our NHS Insight and Interaction services

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

With so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can industry work with the NHS to improve patient flow to get people appropriate treatment sooner and limit the harm caused by waiting?  Prof Phil Richardson (new Chief Innovation Officer, Mtech Access and until recently, Executive Director at NHS Dorset ICS) joins Tom Clarke (Director, Mtech Access) explored all this and more.

In this NHS Whispers webinar, we explore:

 - The pressures facing NHS systems and how this results in patients waiting
 - The long-term impact of this waiting; what it means for patients, their  - outcomes and treatment
 - What informs how NHS system leaders identify and approach these challenges
 - How health and care systems can make effective decisions in this climate
 - How Pharma and Medtech can support system leaders with these challenges

This webinar was first broadcast as a live webinar in November 2022. Learn more.

Discover more about our NHS Insight and Interaction services.

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

How is the NHS balancing competing challenges as we head through integration and towards winter? How are priorities set and what does system planning look like in primary care?

Dr Alex Degan (Primary Care Medical Director, Devon Integrated Care System [ICS]) joins Tom Clarke (Director, Mtech Access) to explore all this and more.

In this episode, we explore how primary care leaders are reacting to the ongoing changes and challenges facing the NHS. Tom Clarke interviews primary care leader Alex Degan to explore:

• How priorities are set and what is driving change
• What system planning looks like in primary care
• The impact of integration – now in practice and for future planning
• How Pharma and Medtech can best support primary care

Learn more on our website.

This podcast was first released as a live webinar on Friday 19th August 2022. Watch the webinar recording here.

Learn more about how Mtech Access delivers authentic NHS insights to support your UK market access strategy. 

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.